Take a look at some of the biggest movers in the premarket: Tesla (TSLA) – Tesla shares rose 3% in the premarket after the company announced it delivered 241,300 vehicles during the third quarter, its most ever for a quarter and a 73% increase over the same quarter a year ago. Moderna (MRNA), Novavax (NVAX)
Tesla (NASDAQ:TSLA) is still not the world’s most valuable carmaker. Toyota Motor (NYSE:TM) is, for now. Its resistance to the EV revolution makes TM stock a problem in the long term. Source: josefkubes / Shutterstock.com With a market cap of $1.28 trillion, on what should be sales of $270 billion in 2021, Toyota dwarfs every competitor. Toyota
Often attributed (though no one knows for sure) to Joseph Kennedy, a nevertheless oft-cited quote states, “If shoeshine boys are giving stock tips, then it’s time to get out of the market.” I don’t want to speak out of turn, but I’m having similar reservations about Sphere 3D (NASDAQ:ANY). Suddenly, it seems everyone is eyeballing
ViacomCBS (NASDAQ:VIAC) has been a costly disappointment for some investors in 2021. Enthusiasm over the company’s newly-announced streaming plans paired with Reddit-fueled retail investors drove VIAC stock past $100 three weeks into March. That was a 174% gain in under four months. Source: Jer123 / Shutterstock.com A catastrophic crash then saw shares lose half their
Engine No. 1, the firm that rose to prominence after waging a successful campaign against Exxon, on Monday announced an investment in General Motors. This time, the upstart activist’s stake signals support for the automaker as it transitions to electric vehicles. Engine No. 1 pointed to the similarities between Exxon and GM, noting that each
In this article FB DD UNP F Facebook’s logo displayed on a phone screen. Jakub Porzycki | NurPhoto via Getty Images Check out the companies making headlines in midday trading. Facebook — Facebook shares fell 5.5% after a company whistleblower unveiled her identify and accused the social media giant of a “betrayal of democracy.” The
A bit of positive news included in Carnival’s (NYSE:CCL) second-quarter results lifted CCL stock in late September. But even as the world appears on track to get “back to normal,” you may not want to buy Carnival’s shares at its present levels. There’s a good chance that the cruise line operator’s results will fully bounce
Recently, Novavax (NASDAQ:NVAX) fell fast. Closing at $207.31 per share on Sept. 30, the vaccine play opened at around $190 on Oct. 1. After that, NVAX stock quickly went into free fall, dropping as low as $154 per share. Source: Ascannio/Shutterstock.com The reason? Breaking news of Merck’s (NYSE:MRK) antiviral Covid-19 pill. Interim results suggest it
On today’s show, Preston and Stig talk about the current market conditions and how they are positioning their portfolio. In the second half of the show, they talk about previous mastermind picks and how they have performed when compared to the S&P500. IN THIS EPISODE, YOU’LL LEARN: – How Preston and Stig’s previous stock picks
I’ve got a question for you. How many shares are you trading currently on per trade basis? How do you decide that? Well, there’s a lot of people out there that wonder exactly this “How many shares should they trade” Should I trade 2 percent of my account size? Or just always trade 100 shares
In the Century of Biology, it pays to own the future of curing disease at the root.
We hear it all the time: The middle class is shrinking. Wages seem to have been stagnant for decades and American families are struggling with financial insecurity. However, what exactly is the middle class? Who is in it, and who is not? Is it shrinking? What about you? Which income class do you belong to?
Hyliion Holdings (NYSE:HYLN) has been a painful investment for many. A year ago, it shares were was trading as high as $55 a piece. Yet its been downhill ever since. I cautioned in March that a HYLN stock investment would require patience. Source: Hyliion media The stock is down nearly 50% since that call. Despite
A year ago, electric vehicles (EVs) were a promising sector for investors. But in 2021, that all changed. Sponsors of special purpose acquisition companies (SPACs) flooded the market with new EV stock investments. Some of these, like Lucid Motors (NASDAQ:LCID), have worked out pretty well. Most, however, have been terrible for investors. Unfortunately, Lordstown Motors
Have you been keeping an eye on the developments in the genetic editing space? We have. Source: Shutterstock And recently, CRISPR gene editing pioneer Feng Zhang achieved a breakthrough in CRISPR therapy cell-delivery. Instead of using the “default” Cas9 enzyme, Zhang used a sub-family of the Cas13 enzyme. One that’s just tiny enough to fit
Here’s a rare opportunity for you. A “next-generation Medicare Advantage insurer,” Clover Health (NASDAQ:CLOV) operates in a high-potential market, providing health care access to seniors and other patient demographics. Yet, CLOV stock is trading at a surprisingly low price. Source: Shutterstock Currently, this stock has landed gently at a strong support level. So, it might be
In this article ATVI DELL OTMO Dell CEO Michael Dell speaks during an interview with CNBC on the floor of the New York Stock Exchange, July 2, 2018 Brendan McDermid | Reuters The fourth quarter has just begun, and Wall Street analysts are picking out the companies they believe have potential for the long run.
With the seemingly worsening crisis of property developer China Evergrande (OTCMKTS:EGRNF), it may be time for investors to at least consider reducing exposure to companies tied to the world’s second-largest economy. Late last week, the Wall Street Journal reported that Evergrande failed to make a scheduled interest payment last Thursday, sparking concerns about a mass
After rising over $100 briefly this year, Cassava Sciences (NASDAQ:SAVA) stock is struggling to rebound. A long document written by the lawyer of a short-seller sent SAVA stock lower. The document challenged the accuracy of some of Cassava’s clinical results Source: Atthapon Raksthaput / Shutterstock.com Cassava has two major clinical studies underway. The top-line data
Listen to Preston’s podcast about studying billionaires here: https://itunes.apple.com/us/podcast/the-investors-podcast/id928933489 Jeff Bezos has been hailed as the richest man in the world, inching out long-time titleholder and Microsoft co-founder Bill Gates. The majority of his earnings came from his online shopping retail site Amazon.com with record-breaking profits from Amazon Prime Day. Huge portions also stemmed from